Hualan Biological Engineering, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001JN8
  • SHE: 002007
CNY
13.30
0.03 (0.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
804.53
762.11
1,216.13
1,580.69
930.59
859.23
888.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
804.53
762.11
1,216.13
1,580.69
930.59
859.23
888.55
Raw Material Cost
490.61
406.97
549.66
605.20
501.42
407.33
380.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.10
0.10
3.86
0.89
2.76
2.74
1.57
Selling and Distribution Expenses
141.86
35.63
253.26
545.22
158.77
49.11
193.73
Other Expenses
5.54
4.91
8.88
6.23
8.15
5.30
10.77
Total Expenditure (Excl Depreciation)
687.93
491.81
895.61
1,213.57
744.40
512.22
683.28
Operating Profit (PBDIT) excl Other Income
116.6
270.3
320.5
367.1
186.20000000000002
347
205.3
Other Income
60.27
20.74
28.83
26.17
35.15
33.80
16.97
Operating Profit (PBDIT)
247.24
348.56
337.71
452.84
292.61
451.90
207.34
Interest
0.10
0.10
3.86
0.89
2.76
2.74
1.57
Exceptional Items
6.52
4.07
-2.17
4.83
7.05
5.45
9.31
Gross Profit (PBDT)
313.91
355.14
666.47
975.49
429.16
451.89
508.30
Depreciation
70.29
70.29
70.74
70.74
70.04
70.04
69.20
Profit Before Tax
183.37
282.24
260.95
386.04
226.87
384.57
145.89
Tax
31.90
46.91
28.64
55.96
28.01
60.74
-4.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
153.01
230.35
155.98
268.56
202.72
313.14
164.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
153.01
230.35
155.98
268.56
202.72
313.14
164.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.41
12.25
16.31
36.45
-3.86
10.70
-19.88
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
152.60
242.59
172.29
305.01
198.86
323.83
144.31
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
0.0
1.0
1.0
Reserves
10,971.60
11,720.32
11,500.61
11,371.87
12,013.17
12,172.14
11,858.78
Earnings per share (EPS)
0.08
0.13
0.09
0.15
0.11
0.17
0.09
Diluted Earnings per share
0.08
0.13
0.09
0.15
0.11
0.17
0.09
Operating Profit Margin (Excl OI)
14.5%
33.79%
19.58%
22.52%
20.14%
40.51%
13.64%
Gross Profit Margin
31.53%
46.26%
27.27%
28.9%
31.91%
52.91%
24.21%
PAT Margin
19.02%
30.23%
12.83%
16.99%
21.78%
36.44%
18.48%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 5.56% vs -37.33% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -37.10% vs 40.80% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -42.95% vs 6.12% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -97.44% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Hualan Biological Engineering, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
804.53
0
804.53
Other Operating Income
0.00
0.00
0.00
Total Operating income
804.53
0
804.53
Raw Material Cost
490.61
0
490.61
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.10
0
0.10
Selling and Distribution Expenses
141.86
0
141.86
Other Expenses
5.54
0.00
5.54
Total Expenditure (Excl Depreciation)
687.93
0
687.93
Operating Profit (PBDIT) excl Other Income
116.59
0.00
116.59
Other Income
60.27
0
60.27
Operating Profit (PBDIT)
247.24
0
247.24
Interest
0.10
0
0.10
Exceptional Items
6.52
0
6.52
Gross Profit (PBDT)
313.91
0
313.91
Depreciation
70.29
0
70.29
Profit Before Tax
183.37
0
183.37
Tax
31.90
0
31.90
Provisions and contingencies
0
0
0.00
Profit After Tax
153.01
0
153.01
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
153.01
0
153.01
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.41
0
-0.41
Other related items
0.00
0.00
0.00
Consolidated Net Profit
152.60
0
152.60
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
10,971.60
0
10,971.60
Earnings per share (EPS)
0.08
0
0.08
Diluted Earnings per share
0.08
0
0.08
Operating Profit Margin (Excl OI)
14.50%
0%
0.00
14.50%
Gross Profit Margin
31.53%
0%
0.00
31.53%
PAT Margin
19.02%
0%
0.00
19.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 80.45 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 5.56% vs -37.33% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -13.55% vs 7.53% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 15.26 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -37.10% vs 40.80% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -23.28% vs 14.05% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.70 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -42.95% vs 6.12% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -27.38% vs 15.32% in Jun 2025

Quarterly - Interest
Interest 0.01 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -97.44% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -96.43% vs -24.32% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.50%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Footer loading